⌘K

Login Start Free

Home/Filings/4/0001562180-23-005476

4//SEC Filing

Koppel Adam 4

Accession 0001562180-23-005476

CIK 0001822462other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 8:12 PM ET

Size

5.3 KB

Accession

0001562180-23-005476

Insider Transaction Report

Form 4

Period: 2023-06-21

Foghorn Therapeutics Inc.FHTX

Director

Transactions

Award
Stock Option (right to buy)
2023-06-21+16,000→ 16,000 total
Exercise: $8.70From: 2024-06-21Exp: 2033-06-20→ Common Stock (16,000 underlying)

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1

filerCIK 0001578965

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 8:12 PM ET
Size: 5.3 KB

View on SEC.gov